The release of TF in lung and vessels following STING over-activation might indeed be a critical event in severe COVID-19, and an important target for other treatments than anti-cytokines, moreover as genetical or pharmacological inhibition of TF abolishes inflammasome-mediated blood clotting, and protects against death [57]. Here, STING1 is linked to COVID-19.